UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 17, 2005
WRIGHT MEDICAL GROUP, INC.
(Exact name of registrant as specified in charter)
| |
|
|
|
|
| Delaware
|
|
000-32883
|
|
13-4088127 |
| (State or other jurisdiction
|
|
(Commission
|
|
(IRS Employer |
| of incorporation)
|
|
File Number)
|
|
Identification No.) |
| |
|
|
| 5677 Airline Road, |
|
|
| Arlington, Tennessee
|
|
38002 |
| (Address of principal executive offices)
|
|
(Zip Code) |
Registrant’s telephone number, including area code: (901) 867-9971
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions:
| |
|
|
o
|
|
Written communications pursuant to
Rule 425 under the Securities Act (17 CFR 230.425)
|
o
|
|
Soliciting material pursuant to
Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
o
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
o
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
TABLE OF CONTENTS
Item 1.01. Entry into a Material Definitive Agreement.
Severance and Release Agreement
On October 17, 2005, we entered into a severance and release agreement with R. Glen Coleman
pursuant to which he was terminated from his position as President of U.S. Sales and Marketing.
The agreement provides that, in exchange for certain releases and covenants by Mr. Coleman, we will
provide him with severance pay consisting of compensation equal to 13 months of his former base
salary, the base salary equivalent of his earned and unused vacation for 2005, and his premiums for
COBRA continuation coverage under our group medical, dental and vision insurance plans for a period
of 12 months. A copy of the severance and release agreement is attached to this report as Exhibit
10.1 and is incorporated herein by reference.
Appointment of Officer
On October 17, 2005, John R. Treace assumed the position of Executive Vice President of U.S. Sales.
Mr. Treace previously served as a Special Assistant to the President of U.S. Sales and Marketing
from January 1, 2004, to October 16, 2005, and as the Vice President of U.S. Sales from 2000 to
2003. In his new position, Mr. Treace will receive a base salary of $230,000 per year, will be
eligible to receive incentive compensation under our executive performance incentive plan, and will
be provided with a temporary housing allowance. In addition, subject to approval by the
Compensation Committee of our Board of Directors, Mr. Treace will receive stock options to purchase
60,000 shares of common stock under our equity incentive plan. The stock options will have an
exercise price equal to the fair market value, as provided in the plan, of our common stock on the
grant date and will vest in full one year after the grant date.
A copy of Mr. Treace’s job offer summary dated October 17, 2005, is attached to this report as
Exhibit 10.2 and is incorporated herein by reference. Mr. Treace is the brother of James T. Treace,
our Chairman of the Board, and the father of John T. Treace, our Vice President and General Manager
of Biologics and Extremities.
Item 9.01. Financial Statements and Exhibits.
(c) Exhibits.
| |
|
|
| Exhibit |
|
|
| Number |
|
Description |
| |
10.1
|
|
Severance and Release Agreement dated as of October 17, 2005,
between Wright Medical Technology, Inc. and R. Glen Coleman. |
|
|
|
10.2
|
|
Job Offer Summary dated October 17, 2005, between Wright Medical
Technology, Inc. and John R. Treace. |
1